Zollinger-Ellison syndrome medical therapy: Difference between revisions

	Zollinger-Ellison syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Zollinger-Ellison syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Zollinger-Ellison syndrome medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Zollinger-Ellison syndrome medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Zollinger-Ellison syndrome medical therapy
CDC on Zollinger-Ellison syndrome medical therapy
Zollinger-Ellison syndrome medical therapy in the news
Blogs on Zollinger-Ellison syndrome medical therapy
Directions to Hospitals Treating Zollinger-Ellison syndrome
Risk calculators and risk factors for Zollinger-Ellison syndrome medical therapy

Revision as of 15:23, 2 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Pharmacologic medical therapies for Zollinger-Ellison syndrome include proton pump inhibitors, H2-receptor antagonists, and Chemotherapy.

Medical therapy for Zollinger-Ellison syndrome may includes the following:^[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{CMG}}
 {{Zollinger-Ellison syndrome}}
+{{CMG}} {{AE}} {{MJK}}
 ==Overview==
+Pharmacologic medical therapies for Zollinger-Ellison syndrome include [[proton pump inhibitor]]s, [[H2-receptor antagonist]]s, and [[Chemotherapy]].
 ==Medical Therapy==
-:*[[Proton pump inhibitor]]s: (such as [[omeprazole]] and [[lansoprazole]]) and histamine [[H2-receptor antagonist]]s (such as [[famotidine]] and [[ranitidine]]) are used to slow down acid secretion. Usual drugs include esomeprazole (Nexium), lansoprazole (Prevacid), pantoprazole (Protonix) and omeprazole (Prilosec).
+Medical therapy for Zollinger-Ellison syndrome may includes the following:<ref name="wikipedia">Wikipedia Zollinger-Ellison syndrome 2015.https://en.wikipedia.org/wiki/Zollinger%E2%80%93Ellison_syndrome</ref>
-:*[[Chemotherapy]]: For those the tumor can not be surgically removed, chemotherapy is available. The drugs include streptozotocin (Zanosar), 5-fluorouracil (Adrucil) and doxorubicin (Doxil).
+*[[Proton pump inhibitor]]s
-:*[[Octreotide]] can be used to slow down acid secretion.
+:*[[Omeprazole]]
+:*[[Lansoprazole]])
+*Histamine [[H2-receptor antagonist]]s
+:*[[Famotidine]]
+:*[[Ranitidine]])
+*[[Chemotherapy]]
+:* Used for tumors that can not be surgically resected
+:*[[Streptozotocin]]
+:*[[5-fluorouracil]]
+:*[[Doxorubicin]]
+*Hormone therapy
+:*[[Octreotide]] can be used to slow down acid secretion
 ==References==
 {{Reflist|2}}